+467.0%
MRNA vs PBR
+74.3%
+392.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PBR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.8% | +6.2% | +5.5% |
| 7D | -1.1% | +5.4% | -6.5% | -1.6% |
| 30D | +126.1% | +22.9% | +103.2% | +123.7% |
| 3M | +190.0% | +19.6% | +170.4% | +189.0% |
| 6M | +157.2% | +16.5% | +140.8% | +152.8% |
| YTD | +388.2% | +86.7% | +301.5% | +355.7% |
| 1Y | +467.0% | +74.7% | +392.3% | +445.6% |
| All | +467.0% | +74.3% | +392.7% | +445.6% |
Cumulative growth
Daily Returns
Daily percentage return beside PBR.
Daily Out/Under-Performance
Portfolio return minus PBR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PBR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PBR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling